- Home
- XYF vs CVRX Comparison
XYF vs CVRX Comparison
Compare XYF & CVRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XYF
- CVRX
- Stock Information
- Founded
- XYF 2014
- CVRX 2000
- Country
- XYF China
- CVRX United States
- Employees
- XYF N/A
- CVRX N/A
- Industry
- XYF Finance: Consumer Services
- CVRX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- XYF Finance
- CVRX Health Care
- Exchange
- XYF Nasdaq
- CVRX Nasdaq
- Market Cap
- XYF 290.2M
- CVRX 337.5M
- IPO Year
- XYF 2018
- CVRX 2021
- Fundamental
- Price
- XYF $6.30
- CVRX $14.85
- Analyst Decision
- XYF
- CVRX Buy
- Analyst Count
- XYF 0
- CVRX 7
- Target Price
- XYF N/A
- CVRX $15.83
- AVG Volume (30 Days)
- XYF 13.9K
- CVRX 405.5K
- Earning Date
- XYF 11-27-2024
- CVRX 10-29-2024
- Dividend Yield
- XYF 5.40%
- CVRX N/A
- EPS Growth
- XYF 18.18
- CVRX N/A
- EPS
- XYF 3.70
- CVRX N/A
- Revenue
- XYF $711,457,433.00
- CVRX $47,255,000.00
- Revenue This Year
- XYF N/A
- CVRX $31.78
- Revenue Next Year
- XYF N/A
- CVRX $26.70
- P/E Ratio
- XYF $1.70
- CVRX N/A
- Revenue Growth
- XYF 26.85
- CVRX 34.38
- 52 Week Low
- XYF $3.48
- CVRX $6.40
- 52 Week High
- XYF $8.59
- CVRX $33.14
- Technical
- Relative Strength Index (RSI)
- XYF 47.90
- CVRX 65.08
- Support Level
- XYF $6.15
- CVRX $13.03
- Resistance Level
- XYF $6.40
- CVRX $15.95
- Average True Range (ATR)
- XYF 0.24
- CVRX 0.79
- MACD
- XYF -0.04
- CVRX -0.22
- Stochastic Oscillator
- XYF 30.23
- CVRX 62.33
About XYF X Financial each representing six
X Financial is a Cayman Islands-based technology-driven personal finance company. Along with its subsidiaries, the firm provides diversified investment opportunities to investors in China through its wealth management platform, Xiaoying Wealth Management. Loan products offered by the company include Xiaoying Card Loan, Xiaoying Preferred Loan, and Xiaoying Housing Loan. The company generates revenue from loan facilitation service, post-origination service, and guarantee services provided.
About CVRX CVRx Inc.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.